| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| Gene symbol | SDC1 | Synonyms | CD138, SDC, SYND1, syndecan | Type of gene | protein-coding |
| Chromosome | 2 | Map location | 2p24.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | syndecan 1 | ||||
| Gene symbol | CD38 | Synonyms | ADPRC 1, ADPRC1, cADPR1 | Type of gene | protein-coding |
| Chromosome | 4 | Map location | 4p15.32 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | CD38 molecule | ||||
| Gene symbol | CSH1 | Synonyms | CS-1, CSA, CSMT, GHB3, PL, hCS-1, hCS-A | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q23.3 | dbXrefs | |
| Description | chorionic somatomammotropin hormone 1 | ||||
| Gene symbol | ITGB7 | Synonyms | None | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12q13.13 | dbXrefs | |
| Description | integrin subunit beta 7 | ||||
| GTO ID | GTC2035 |
| Trial ID | NCT03778346 |
| Disease | Multiple Myeloma |
| Altered gene | ITGB7|BCMA|CS1|CD38|CD138 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Generation | 4th |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Integrin β7, BCMA, CS1, CD38 and CD138 as the Single or Compound Targets for the Fourth Genenation of CAR-T Cells |
| Year | 2018 |
| Country | China |
| Company sponsor | The Sixth Affiliated Hospital of Wenzhou Medical University |
| Other ID(s) | SixthAHWenzhouMU |
| Cohort 1 | |||||||
|
|||||||